8th Annual Clinical Quality Oversight Forum
With the adoption of ICH E6 (R2) by the EMA this month, and planned adoption for the FDA later this year, this event has never been more important or relevant to the way in which we conduct and oversee clinical trials.
TRI’s CEO Duncan Hall will be presenting alongside Advanced Clinical’s SVP of Clinical and Medical Operations, Cheryle Evans.
For more information on Advanced Clinical, please follow this link: Advanced Clinical
Duncan and Cheryle will be presenting a case study on achieving R2 compliance, and how Advanced Clinical are able to support their sponsor clients in facilitating ongoing quality oversight and management during the course of a clinical trial. Case studies such as this one give an important insight into how the industry is moving from ‘theory into practice’ and will be relevant for any sponsor or CRO organisation who is planning to run clinical trials under the new R2 guidance.
To register for the event, please follow the link: Event Registration.
Due to TRI’s sponsorship of the event, we are also able to offer a limited number of discount codes to our industry contacts:
In order to receive your discount code (which you will need as part of the registration process) please email us at firstname.lastname@example.org
Event Synopsis and Agenda:
To find out more about the event, who is speaking, the round table topics and details of the location, please click on the following link: Event Details.